Crohn's disease

This study looks at upadacitinib in people with Crohn’s disease who did not respond to anti-TNF drugs — a common and challenging clinical situation.

Cure8 could only read part of this source from hcplive.com, so this card uses cautious topic tags instead of a full summary. It is tagged for Crohn's disease, Inflammatory bowel disease, and Risankizumab.

Cure8 found this source from youtube.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Research and clinical trials. Open the original article for the...

Starting college brings new routines, living situations, and social pressures that can affect IBD management. Practical planning around food, medications, stress, and support can help reduce the risk of flares and make...

Mucosal healing is a treatment goal that aims to stop internal intestinal inflammation, not just symptoms. Achieving mucosal healing is linked with fewer hospitalizations, less need for surgery, and lower rates of...

Based on the title and source metadata, this appears to be a regulatory update related to Crohn's disease, Inflammatory bowel disease, and Ustekinumab. The original article is from jnj.com.

Based on the title and source metadata, this appears to be a patient education related to Inflammatory bowel disease, Crohn's disease, and Community and awareness. The original article is from msn.com.

This report summarizes recent late-stage trial results, regulatory actions, and new biosimilar launches that could affect treatment options, availability, and drug costs in Crohn’s disease over the coming years.

Market shifts influence availability, cost, and development of new Crohn's disease treatments. Wider use of biosimilars and growth in biologics/small molecules can affect access and treatment choices over time.

Based on the title and source metadata, this appears to be a patient story related to Crohn's disease, Inflammatory bowel disease, and Community and awareness. The original article is from msn.com.

This study tests a live Faecalibacterium prausnitzii probiotic (EXL01) as a way to prolong steroid-induced remission in Crohn’s disease, a potential new strategy to reduce relapses and steroid exposure.

This work targets a possible root cause (epithelial stress and cell death) rather than only suppressing inflammation — if validated in humans, it could offer new treatment options for people who don’t respond to current...

This study suggests a different treatment target for Crohn’s disease: fixing damaged intestinal lining rather than only suppressing inflammation. If validated in humans, repurposed cancer drugs could speed development of...

Based on the title and source metadata, this appears to be a clinical study related to Crohn's disease, Inflammatory bowel disease, and Research and clinical trials. The original article is from msn.com.

This study suggests a new treatment angle for Crohn’s disease by targeting epithelial cell stress and barrier repair rather than only dampening immune inflammation. If validated in clinical trials, it could lead to...

A subcutaneous induction option for SKYRIZI could let people with Crohn’s start and continue treatment with injections instead of beginning with an IV infusion, which may affect convenience, time in clinic, and infusion...

The study identifies a specific protein interaction that may underlie persistent inflammation; for people with Crohn’s and other inflammatory conditions this points to a potential new, more targeted treatment approach in...

Based on the title and source metadata, this appears to be a basic science related to Crohn's disease and Research and clinical trials. The original article is from msn.com.

Based on the title and source metadata, this appears to be a patient story related to Crohn's disease, Inflammatory bowel disease, and Community and awareness. The original article is from msn.com.

How “moderate” IBD is defined affects who is enrolled in trials, who is offered advanced therapies, and how clinicians make treatment decisions. Inconsistent definitions could delay appropriate care for people who might...

This analysis summarizes longer-term safety data for upadacitinib (Rinvoq) in people with moderate to severe ulcerative colitis and Crohn’s disease.

Cure8 found this source from abs-cbnnews.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Community and awareness. Open the original article for the full...

The study suggests vitamin D might help the immune system tolerate gut bacteria better and lower intestinal inflammation, which could mean fewer symptoms or flares for people with Crohn’s disease or ulcerative colitis.

Based on the title and source metadata, this appears to be an event or fundraiser related to Inflammatory bowel disease, Crohn's disease, and Community and awareness. The original article is from msn.com.

Early clinical data suggest PALI-2108 may affect both inflammation and fibrosis in Crohn’s disease and shows biomarker changes (like fecal calprotectin) that could matter to people monitoring disease activity.

Cure8 found this source from journals.sagepub.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Corticosteroids. Open the original article for the full...

Based on the title and source metadata, this appears to be a patient education related to Inflammatory bowel disease, Crohn's disease, and Community and awareness. The original article is from msn.com.

Cure8 found this source from insidehalton.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Community and awareness. Open the original article for the...

Cure8 could only read part of this source from gurufocus.com, so this card uses cautious topic tags instead of a full summary. It is tagged for Crohn's disease, Inflammatory bowel disease, and Medications.

Cure8 found this source from huffpost.com, but the page could not be read reliably yet. It is tagged for Crohn's disease and Community and awareness. Open the original article for the full details.

Cure8 found this source from youtube.com, but the page could not be read reliably yet. It is tagged for Inflammatory bowel disease, Crohn's disease, and Community and awareness. Open the original article for the full...

Fundraising events like this support research, education, and patient services for Crohn’s disease and ulcerative colitis. They also raise public awareness and honor people who contribute to the IBD community.

A real patient story showing how Crohn’s disease can start with vague symptoms and take years to diagnose may help others recognize when to seek further evaluation. It also describes common diagnostic tests used for IBD.

Based on the title and source metadata, this appears to be a patient story related to Crohn's disease, Inflammatory bowel disease, and Community and awareness. The original article is from msn.com.

Cure8 found this source from tipranks.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Imaging. Open the original article for the full details.

Cure8 found this source from yahoo.com, but the page could not be read reliably yet. It is tagged for Inflammatory bowel disease, Crohn's disease, and Community and awareness. Open the original article for the full...

Cure8 could only read part of this source from aol.com, so this card uses cautious topic tags instead of a full summary. It is tagged for Crohn's disease, Inflammatory bowel disease, and Community and awareness.

Cure8 found this source from wfla.com, but the page could not be read reliably yet. It is tagged for Inflammatory bowel disease, Crohn's disease, and Community and awareness. Open the original article for the full...

Based on the title and source metadata, this appears to be a clinical study related to Crohn's disease, Inflammatory bowel disease, and Diet and lifestyle. The original article is from msn.com.

Treg cell therapy aims to reduce harmful immune activity that drives Crohn's disease. If developed successfully, it could become a targeted cell-based treatment option for patients who don't respond to current therapies.

Based on the title and source metadata, this appears to be a basic science related to Crohn's disease and Complications. The original article is from msn.com.

Based on the title and source metadata, this appears to be a clinical study related to Crohn's disease, Inflammatory bowel disease, and Research and clinical trials. The original article is from pressreader.com.

This research suggests genetic risk scores could help identify people with IBD who are more likely to have severe disease, which might eventually inform earlier monitoring or treatment decisions. It’s a step toward more...

Based on the title and source metadata, this appears to be an opinion or commentary related to Crohn's disease, Inflammatory bowel disease, and Research and clinical trials. The original article is from...

Based on the title and source metadata, this appears to be a basic science related to Crohn's disease and Research and clinical trials. The original article is from bernama.com.

Based on the title and source metadata, this appears to be a low information aggregator related to Crohn's disease, Inflammatory bowel disease, and Tests and monitoring. The original article is from pressreader.com.

Fibrosis (scarring) in Crohn’s can narrow the bowel and lead to surgery. A discovery about immune cells that drive fibrosis could eventually point to treatments that reduce or prevent scarring.

Fibrosis and repeated bowel surgery are a major problem for many people with Crohn’s disease; research that could prevent or treat bowel scarring could reduce the need for operations and improve long-term outcomes.